Filters
cris logo
-
New search Filters
Select from list
Displayed from Show more
You have reached the maximum number of displayed search results.
All results displayed
No results are available for the search performed
Displayed from
You have reached the maximum number of displayed search results.
All results displayed
Loading results
Obtaining statistical data

PhD Urša Lampreht Tratar

PhD Urša Lampreht Tratar
no.: 36367 source: ARIS

researcher – active in research organisation
Edit
Research activity

Code Science Field Subfield
3.04.00  Medical sciences  Oncology   
4.04.03  Biotechnical sciences  Veterinarian medicine  Therapy and health prevention of animals 
Bibliography Representative bibliographic units | Personal| COBISS+
source: COBISS
source: SICRIS
Evaluation (rules)
Evaluation of bibliographic research performance indicators according to ARIS methodology
source: COBISS
source: ARIS
Points
245.68
A''
0
A'
138.74
A1/2
190.69
CI10
435
CImax
120
h10
12
A1
0.88
A3
0.11
Data for the last 5 years (citations for the last 10 years) on April 19, 2024; A3 for period 2018-2022 (update for tender in 2023: YES)
Data for ARIS tenders ( 12.01.2024 – Project tender, archive )
Citations Citations for bibliographic records in COBIB.SI that are linked to records in citation databases
source: WoS source: Scopus source: COBISS
Database Linked records Citations Pure citations Average pure citations
WoS 35  530  345  9.86 
Scopus 33  619  434  13.15 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group
Full time employment (100%, RD:100%)  Institute of Oncology Ljubljana  Department of research 
Research projects Legend
source: ARIS
no. Code Title Period Head
1. J3-50108  DEBIO 1143 has a potential to increase effectiveness of electrochemotherapy and radiotherapy in HPV positive and HPV negative Head and Neck Cancers   2023 - 2024  PhD Katarina Žnidar  2,191 
2. J4-50150  Erythrocyte membrane-based nanocarriers for gene silencing cancer therapy   2023 - 2024  PhD Nina Kostevšek  3,902 
3. L3-50111  Gene immuno-therapy of solid tumors based on mRNA encoding interleukin-12: So-rIL   2023 - 2024  PhD Maja Čemažar  2,831 
4. J3-50110  Intratumoral mRNA electrotransfer: establishment and preclinical proof of concept   2023 - 2024  PhD Katja Uršič Valentinuzzi  3,082 
5. L7-4491  Development of integrated multi-channel artificial nose for detection of cancer   2022 - 2024  PhD Igor Muševič  5,467 
6. J1-4417  Development of novel small molecule Toll-like receptors 7 and 8 modulators for cancer immunotherapy   2022 - 2024  PhD Matej Sova  3,917 
7. J7-4635  MitoCan - Preclinical development of new Mitochondrial ion channel inhibitors for Cancer therapy   2022 - 2024  PhD Lucija Peterlin Mašič  6,047 
8. J3-4504  Uncovering the glioblastoma microenvironment to enhance the therapy   2022 - 2024  PhD Metka Novak  1,771 
9. J3-3084  Inducible Programming of CAR T Cell Intrinsic Properties for Cancer Immunotherapy   2021 - 2024  PhD Anže Smole  2,497 
10. J3-3083  Vascularization and vascular effects as predictive factors for local ablative techniques   2021 - 2024  PhD Gregor Serša  6,766 
11. J3-2529  Role of endothelium in tumor response to radiotherapy   2022 - 2023  PhD Boštjan Markelc  3,335 
12. J7-2594  The amniotic membrane as a novel multimodal therapy for bacterial cystitis and bladder cancer: unravelling its antimicrobial, immunomodulatory and anticancer activity   2022 - 2023  PhD Mateja Erdani Kreft  5,128 
13. J3-2528  Immuno gene electrotransfer of IL-12 and IL-2 in immunologically cold/hot tumors   2020 - 2023  PhD Maja Čemažar  3,171 
14. J4-2546  Monitoring of the clinical and immune response to improve the outcome of combined electrochemotherapy and IL-12 gene therapy in dogs with spontaneous peripheral tumours   2020 - 2023  PhD Nataša Tozon  3,554 
15. J3-9269  Clinico-pharmacological approach to optimize the therapeutic bleomycin concentration in patients undergoing electrochemotherapy   2018 - 2021  PhD Gregor Serša  3,493 
16. J3-8202  Time-lapse intra-vital imaging of immune response after electrochemotherapy induced in situ vaccination and Interleukin-12 gene therapy boost   2017 - 2018  PhD Maja Čemažar  3,536 
17. J3-7460  Irradiation dose modifying factor of squamous cell carcinoma of the oropharynx infected by human papillomavirus: an in vitro and in vivo study in laboratory mouse tumor model   2016 - 2018  PhD Primož Strojan  4,254 
18. J3-6793  New approaches of tumor radiosenzibilization with gene therapy   2014 - 2017  PhD Gregor Serša  5,089 
19. J3-6796  Translational oncology: development and validtion of immunogene therapy with Interleukin-12 combined with surgery for canine cancers of the oral cavity and skin   2014 - 2017  PhD Maja Čemažar  4,736 
ARIS research and infrastructure programmes Legend
source: ARIS
no. Code Title Period Head
1. P3-0428  Comparative oncology for tackling rare cancers   2023 - 2024  PhD Ario de Marco  903 
2. P3-0003  Development and evaluation of new approaches to cancer treatment   2022 - 2023  PhD Gregor Serša  3,943 
3. P3-0003  Development and evaluation of new approaches to cancer treatment   2015 - 2021  PhD Gregor Serša  3,261 
4. P3-0003  Development and evaluation of new approaches to cancer treatment   2013 - 2014  PhD Gregor Serša  4,015 
We were not given permission by the researcher to publish data.
Confirmation required
Views history
Favourite